Metascoring and gene expression profiling in multiple myeloma

被引：0
|
作者：
Meissner, T. [1 ]
Seckinger, A. [1 ]
Reme, T. [2 ,3 ]
Hielscher, T. [4 ]
Moehler, T. [1 ]
Neben, K. [1 ]
Goldschmidt, H. [1 ,5 ]
Klein, B. [2 ,3 ]
Hose, D. [1 ,5 ]
机构：
[1] Univ Klinikum Heidelberg, Med Klin 5, D-6900 Heidelberg, Germany
[2] INSERM, U847, Montpellier, France
[3] CHU Montpellier, Montpellier, France
[4] Deutsch Krebsforschungszentrum, Heidelberg, Germany
[5] Natl Ctr Tumorerkrankungen, Heidelberg, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [31] Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment
    Cerchione, Claudio
    Usmani, Saad Z.
    Stewart, A. Keith
    Kaiser, Martin
    Rasche, Leo
    Kortuem, Martin
    Mateos, Maria-Victoria
    Spencer, Andrew
    Sonneveld, Pieter
    Anderson, Kenneth C.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Expression of PRAME gene in multiple myeloma
    Abramenko, IB
    Belous, NI
    Kryachok, IA
    Chumak, AA
    Aksenova, EV
    Lisovskaya, EV
    Misyurin, AV
    TERAPEVTICHESKII ARKHIV, 2004, 76 (07): : 77 - 81
  • [33] Multiple sclerosis and gene expression profiling
    Steinman, L
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VIII: AUTOIMMUNITY 2000 AND BEYOND, 2001, 490 : 109 - 112
  • [34] Gene Expression Profiling in Multiple Myeloma-Reporting of Entities, Risk, and Targets in Clinical Routine
    Meissner, Tobias
    Seckinger, Anja
    Reme, Thierry
    Hielscher, Thomas
    Moehler, Thomas
    Neben, Kai
    Goldschmidt, Hartmut
    Klein, Bernard
    Hose, Dirk
    CLINICAL CANCER RESEARCH, 2011, 17 (23) : 7240 - 7247
  • [35] Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma
    Mitra, Amit Kumar
    Ramakrishnan, Vijay G.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Van Ness, Brian G.
    BLOOD, 2017, 130
  • [36] Genome-wide profiling of gene expression and DNA copy number alterations in multiple myeloma
    Keats, Jonathan
    Chapman, Mike
    Carpten, John
    Chng, Wee-Joo
    Baker, Angela
    Ahmann, Gregory
    Trudel, Suzanne
    Siegel, David
    Rajkumar, S. Vincent
    Alsina, Melissa
    Richardson, Paul
    Anderson, Kenneth
    Auclair, Daniel
    Perkins, Louise M.
    Trent, Jeffrey
    Golub, Todd R.
    Fonseca, Rafael
    BLOOD, 2007, 110 (11) : 123A - 123A
  • [37] Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing
    Agnelli, Luca
    Tassone, Pierfrancesco
    Neri, Antonino
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 : S55 - S68
  • [38] Gene expression profiling in multiple myeloma cells treated with the novel anti-myeloma agents zoledronate and fluvastatin.
    Molloy, TJ
    Cindy, BB
    Deng, YM
    Spencer, A
    Ma, DF
    BLOOD, 2005, 106 (11) : 351B - 351B
  • [39] Metaphase cytogenetics adds to gene expression profiling in the identification of high risk multiple myeloma.
    Tricot, Guido
    Zhan, Fenghuang
    Barlogie, Bart
    Huang, Yongsheng
    Sawyer, Jeffrey
    Shaughnessy, John
    BLOOD, 2006, 108 (11) : 38A - 38A
  • [40] A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
    Awada, Hassan
    Thapa, Bicky
    Awada, Hussein
    Dong, Jing
    Gurnari, Carmelo
    Hari, Parameswaran
    Dhakal, Binod
    CELLS, 2021, 10 (08)
12345